July 25, 2013

Cornerstone recently launched, a comprehensive guide to health technology assessments and decision-making undertaken by the following agencies:

  • The pan-Canadian Oncology Drug Review (pCODR)
  • The Common Drug Review (CDR)
  • The National Institute of Clinical Excellence (NICE)
  • The Institute for Quality and Efficiency in Healthcare/Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesenis (IQWiG)

The site also features comparisons of decisions on oncology products made by global reimbursement and health technology assessment agencies.  These comparisons promote an understanding of successful strategies, common criticisms and mistakes, and regional variations in health care decision-making.

Visit to access up-to-date information on the latest market access, pricing, and reimbursement information.

Copyright © 2019. All Rights Reserved. Cornerstone Research Group